研究者
J-GLOBAL ID：200901008194322231
更新日: 2023年12月30日
稲垣 淳
イナガキ アツシ | Inagaki Atsushi
所属機関・部署：
職名：
助教
競争的資金等の研究課題 (1件)：
論文 (39件)：
-
Tomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki, Hiroya Hashimoto, Nozomi Nishitarumizu, Yoko Nakanishi, Yukiyasu Kato, Akimi Kawai, Naohiro Matsunaga, Toru Ebina, et al. Humoral and cellular immune response to second and third severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with plasma cell dyscrasia. Cancer medicine. 2023. 12. 12. 13135-13144
-
Tomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki, Hiroya Hashimoto, Nozomi Nishitarumizu, Yoko Nakanishi, Yukiyasu Kato, Akimi Kawai, Naohiro Matsunaga, Toru Ebina, et al. A comprehensive evaluation of humoral immune response to second and third SARS-CoV-2 mRNA vaccination in patients with malignant lymphoma. International journal of hematology. 2023. 117. 6. 1-10
-
Nana Suzuki, Toru Okuyama, Tatsuo Akechi, Shigeru Kusumoto, Masaki Ri, Atsushi Inagaki, Satoshi Kayukawa, Hiroki Yano, Takashi Yoshida, Kazuhide Shiraga, et al. Symptoms and health-related quality of life in patients with newly diagnosed multiple myeloma: a multicenter prospective cohort study. Japanese journal of clinical oncology. 2022. 52. 2. 163-169
-
Yoshiaki Marumo, Shigeru Kusumoto, Ayako Masaki, Takahiro Nakashima, Takaki Kikuchi, Fumiko Mori, Hirokazu Komatsu, Hiroshi Inagaki, Shinsuke Iida, Atsushi Inagaki. Newly diagnosed follicular lymphoma during pembrolizumab treatment for lung cancer. International journal of hematology. 2021. 114. 2. 280-285
-
Takashi Kanamori, Masashi Sanada, Masaki Ri, Hiroo Ueno, Dai Nishijima, Takahiko Yasuda, Takuto Tachita, Tomoko Narita, Shigeru Kusumoto, Atsushi Inagaki, et al. Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort. British journal of haematology. 2020. 191. 5. 755-763
もっと見る
MISC (16件)：
-
Tomoko Narita, Atsushi Inagaki, Tsutomu Kobayashi, Yoshiaki Kuroda, Toshihiro Fukushima, Masahiko Nezu, Shin-ichi Fuchida, Hirotaka Sakai, Naohiro Sekiguchi, Isamu Sugiura, et al. Chromosomal Translocation (14;16)-Positive Multiple Myeloma Shows Negativity for CD56 Expression and Unfavorable Outcome Even in the Era of Novel Drugs. BLOOD. 2014. 124. 21
-
Asahi Ito, Fumihiko Sato, Takashi Ishida, Fumiko Mori, Hisashi Takino, Atsushi Inagaki, Masaki Ri, Shigeru Kusumoto, Hirokazu Komatsu, Shinsuke Iida, et al. A Complement-Dependent Cytotoxicity-Enhancing Anti-CD20 Antibody Mediating Potent Antitumor Activity In the Humanized NOD/Shi-Scid, IL-2R gamma null Mouse Lymphoma Model. BLOOD. 2010. 116. 21. 189-189
-
稲垣 淳, 楠本 茂. 抗菌薬不応性発熱性好中球減少患者にいつ抗真菌薬治療を開始するか? 'Empirical versus preemptive antifungal therapy for high-risk, fabrile, neutropenic patients: a randomized, controlled trial'Condonnier C, et al. 深在性真菌症. 2010. 6. 2. 48-54
-
稲垣 淳, 楠本 茂. がん患者におけるウイルス感染症 (特集 抗がん剤の副作用と支持療法). 腫瘍内科. 2010. 5. 3. 329-337
-
Masaki Ri, Shinsuke Iida, Takayuki Nakashima, Hideyuki Miyazaki, Fumiko Mori, Asahi Ito, Atsushi Inagaki, Shigeru Kusumoto, Takashi Ishida, Hirokazu Komatsu, et al. Establishment and Characterization of Bortezomib-Resistant Myeloma Cell Lines: A Possible Role of Mutated Proteasome beta 5 Subunit in Preventing the Accumulation of Unfolded Protein, Which Is Otherwise Followed by Catastrophic Endoplasmic Reticulum (ER) Stress. BLOOD. 2009. 114. 22. 1451-1451
もっと見る
前のページに戻る
